(VIANEWS) - Riot Blockchain (RIOT), Crexendo (CXDO), Solar Capital Ltd. (SLRC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Riot Blockchain (RIOT)
1611.2% sales growth and 7.84% return on equity
Riot Blockchain's sales growth this year is anticipated to be 1681.8% and 94.4% for next year.
Year-on-year quarterly revenue growth grew by 1668.7%, now sitting on 65.3M for the twelve trailing months.
Volume
Today's last reported volume for Riot Blockchain is 7335610 which is 25.93% below its average volume of 9904230.
Riot Blockchain's sales growth is a negative 0% for the present quarter and 1611.2% for the next. The company's growth estimates for the present quarter and the next is 700% and 125%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.84%.
Volatility
Riot Blockchain's last day, last week, and last month's current intraday variation average was 0.43%, 2.56%, and 5.42%, respectively.
Riot Blockchain's highest amplitude of average volatility was 7.62% (day), 6.93% (last week), and 9.39% (last month), respectively.
Riot Blockchain's Stock Yearly Top and Bottom Value
Riot Blockchain's stock is valued at $20.84 at 06:22 EST, way below its 52-week high of $79.50 and way higher than its 52-week low of $8.90.
Riot Blockchain's Moving Average
Riot Blockchain's worth is way under its 50-day moving average of $31.38 and way below its 200-day moving average of $35.49.Previous days news about Riot Blockchain(RIOT)
- According to Bloomberg Quint on Sunday, 20 March, "Earlier adopters of Bitcoin mining in the U.S. such as Marathon and Riot Blockchain Inc. are still dominant in terms of computing power. "
2. Crexendo (CXDO)
66.6% sales growth and 12.99% return on equity
Crexendo, Inc. provides cloud communication, unified communications as a service, call center, collaboration, and other cloud business services for businesses in the United States, Canada, and internationally.
Crexendo's sales growth this year is expected to be 41.6% and 20.3% for next year.
Year-on-year quarterly revenue growth grew by 112.6%, now sitting on 23.42M for the twelve trailing months.
Volume
Today's last reported volume for Crexendo is 39015 which is 12.77% above its average volume of 34595.
Crexendo's sales growth for the next quarter is 66.6%. The company's growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.99%.
Volatility
Crexendo's last day, last week, and last month's current intraday variation average was 5.84%, 3.49%, and 2.60%, respectively.
Crexendo's highest amplitude of average volatility was 7.39% (day), 7.26% (last week), and 6.39% (last month), respectively.
Crexendo's Stock Yearly Top and Bottom Value
Crexendo's stock is valued at $4.35 at 06:22 EST, way under its 52-week high of $7.20 and way above its 52-week low of $3.60.
Crexendo's Moving Average
Crexendo's value is higher than its 50-day moving average of $4.16 and way under its 200-day moving average of $5.30.Previous days news about Crexendo(CXDO)
- According to Benzinga on Monday, 21 March, "• Crexendo (NASDAQ:CXDO) is estimated to report quarterly earnings at $0.03 per share on revenue of $8.82 million."
3. Solar Capital Ltd. (SLRC)
25% sales growth and 7.03% return on equity
Solar Capital Ltd.
Solar Capital Ltd.'s sales growth this year is anticipated to be 24.5% and 11.9% for next year.
Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 139.35M for the twelve trailing months.
Volume
Today's last reported volume for Solar Capital Ltd. is 513524 which is 190.85% above its average volume of 176554.
Solar Capital Ltd.'s sales growth for the next quarter is 25%. The company's growth estimates for the current quarter and the next is a negative 2.7% and 2.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.03%.
Solar Capital Ltd.'s Stock Yearly Top and Bottom Value
Solar Capital Ltd.'s stock is valued at $17.80 at 06:22 EST, way below its 52-week high of $20.05 and higher than its 52-week low of $17.32.
Solar Capital Ltd.'s Moving Average
Solar Capital Ltd.'s worth is under its 50-day moving average of $18.31 and below its 200-day moving average of $18.91.4. Champions Oncology (CSBR)
21.1% sales growth and 5.23% return on equity
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States.
Champions Oncology's sales growth this year is expected to be 17.7% and 17.2% for next year.
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 44.41M for the twelve trailing months.
Volume
Today's last reported volume for Champions Oncology is 11476 which is 49.71% above its average volume of 7665.
Champions Oncology's sales growth is a negative 0% for the current quarter and 21.1% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 60% and 175%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.23%.
Volatility
Champions Oncology's last day, last week, and last month's current intraday variation average was 0.24%, 3.28%, and 2.08%, respectively.
Champions Oncology's highest amplitude of average volatility was 4.36% (day), 9.15% (last week), and 7.18% (last month), respectively.
Champions Oncology's Stock Yearly Top and Bottom Value
Champions Oncology's stock is valued at $8.46 at 06:22 EST, way under its 52-week high of $13.14 and way higher than its 52-week low of $7.06.
Champions Oncology's Moving Average
Champions Oncology's value is above its 50-day moving average of $7.96 and under its 200-day moving average of $9.20.Previous days news about Champions Oncology(CSBR)
- Here's how much you would have made owning champions oncology stock in the last 5 years. According to Benzinga on Monday, 21 March, "Buying $1,000 In CSBR: 5 years ago, an investor could have purchased 316.46 shares of Champions Oncology at the time with $1,000. "
5. First Eagle Alternative Capital BDC (FCRD)
19.2% sales growth and 10.31% return on equity
THL Credit, Inc. is a business development company specializing in direct and fund of fund investments.
First Eagle Alternative Capital BDC's sales growth this year is expected to be 7% and 9.4% for next year.
Year-on-year quarterly revenue growth grew by 14.1%, now sitting on 30.84M for the twelve trailing months.
Volume
Today's last reported volume for First Eagle Alternative Capital BDC is 9427 which is 75.42% below its average volume of 38363.
First Eagle Alternative Capital BDC's sales growth for the next quarter is 19.2%. The company's growth estimates for the current quarter and the next is a negative 9.1% and negative -9.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.31%.
Volatility
First Eagle Alternative Capital BDC's last day, last week, and last month's current intraday variation average was 0.69%, 0.97%, and 0.89%, respectively.
First Eagle Alternative Capital BDC's highest amplitude of average volatility was 1.62% (day), 1.96% (last week), and 2.41% (last month), respectively.
First Eagle Alternative Capital BDC's Stock Yearly Top and Bottom Value
First Eagle Alternative Capital BDC's stock is valued at $4.35 at 06:22 EST, way below its 52-week high of $4.89 and way higher than its 52-week low of $3.94.
First Eagle Alternative Capital BDC's Moving Average
First Eagle Alternative Capital BDC's value is under its 50-day moving average of $4.45 and under its 200-day moving average of $4.57.6. Tri Pointe Homes (TPH)
5.2% sales growth and 20.05% return on equity
Tri Pointe Homes, Inc. engages in the design, construction, and sale of single-family attached and detached homes in the United States.
Tri Pointe Homes's sales growth this year is expected to be 12.3% and 10.4% for next year.
Year-on-year quarterly revenue growth grew by 14.1%, now sitting on 3.98B for the twelve trailing months.
Volume
Today's last reported volume for Tri Pointe Homes is 734672 which is 44.21% below its average volume of 1316920.
Tri Pointe Homes's sales growth for the next quarter is 5.2%. The company's growth estimates for the ongoing quarter and the next is 3.4% and 26%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.05%.
Volatility
Tri Pointe Homes's last day, last week, and last month's current intraday variation average was 0.41%, 1.04%, and 2.00%, respectively.
Tri Pointe Homes's highest amplitude of average volatility was 2.49% (day), 3.56% (last week), and 3.66% (last month), respectively.
Tri Pointe Homes's Stock Yearly Top and Bottom Value
Tri Pointe Homes's stock is valued at $22.14 at 06:22 EST, way below its 52-week high of $28.29 and way higher than its 52-week low of $18.87.